Life ScienceCompany
T3S Technologies - Bacterial Secretion Platform Ownership
Who owns T3S Technologies - Bacterial Secretion Platform?
T3S Technologies - Bacterial Secretion Platform is owned by Vectron Biosolutions AS. It was acquired on June 17, 2021.
T3S Technologies - Bacterial Secretion Platform Business Overview
Where is T3S Technologies - Bacterial Secretion Platform headquartered?
T3S Technologies - Bacterial Secretion Platform is headquartered in Salt Lake City, Utah.
What sector is T3S Technologies - Bacterial Secretion Platform in?
T3S Technologies - Bacterial Secretion Platform is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 398 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 352 by strategics.